116 related articles for article (PubMed ID: 34472681)
1. Long-term persistence of hepatocarcinogenic potential of a non-hypervascular hypointense nodule on EOB-MRI after the eradication of hepatitis C virus.
Toyoda H; Yasuda S; Shiota S; Kumada T
Hepatol Res; 2022 Jan; 52(1):128-132. PubMed ID: 34472681
[TBL] [Abstract][Full Text] [Related]
2. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Eur Radiol; 2022 Jul; 32(7):5016-5023. PubMed ID: 35142900
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Aliment Pharmacol Ther; 2021 Jun; 53(12):1309-1316. PubMed ID: 33896023
[TBL] [Abstract][Full Text] [Related]
4. The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.
Toyoda H; Kumada T; Tada T; Mizuno K; Sone Y; Akita T; Tanaka J; Johnson PJ
Liver Int; 2019 Mar; 39(3):448-454. PubMed ID: 30312003
[TBL] [Abstract][Full Text] [Related]
5. Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver.
Shimizu Y; Arai K; Yamashita T; Yamashita T; Shimakami T; Kawaguchi K; Kitamura K; Sakai Y; Mizukoshi E; Honda M; Kitao A; Kozaka K; Kobayashi S; Kaneko S
Liver Cancer; 2020 Jun; 9(3):261-274. PubMed ID: 32647630
[TBL] [Abstract][Full Text] [Related]
6. Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments.
Toyoda H; Kumada T; Tada T; Mizuno K; Sone Y; Kaneoka Y; Maeda A; Akita T; Tanaka J
Aliment Pharmacol Ther; 2018 Sep; 48(6):664-670. PubMed ID: 30047149
[TBL] [Abstract][Full Text] [Related]
7. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
8. The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C.
Toyoda H; Tada T; Yasuda S; Mizuno K; Sone Y; Kaneoka Y; Maeda A; Akita T; Tanaka J; Kumada T
Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1232-1238. PubMed ID: 31588590
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Gd-EOB-DTPA-enhanced MRI for evaluating the potential for early development of hepatocellular carcinoma after HCV eradication by direct-acting antiviral treatment.
Morimoto N; Miura K; Watanabe S; Tsukui M; Takaoka Y; Nomoto H; Murayama K; Hirosawa T; Goka R; Kunitomo N; Nakamura H; Sugimoto H; Isoda N; Yamamoto H
J Rural Med; 2019 May; 14(1):78-86. PubMed ID: 31191770
[No Abstract] [Full Text] [Related]
10. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
11. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
12. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
13. The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
Wang F; Numata K; Chuma M; Nihonmatsu H; Moriya S; Nozaki A; Ogushi K; Fukuda H; Okada M; Ruan L; Luo W; Koizumi N; Nakano M; Otani M; Inayama Y; Maeda S
Abdom Radiol (NY); 2021 Jun; 46(6):2527-2539. PubMed ID: 33388895
[TBL] [Abstract][Full Text] [Related]
14. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI.
Takeishi K; Yoshizumi T; Itoh S; Yugawa K; Yoshiya S; Toshima T; Harada N; Ikegami T; Nishie A; Mori M
Ann Surg Oncol; 2020 Sep; 27(9):3344-3353. PubMed ID: 32246316
[TBL] [Abstract][Full Text] [Related]
15. Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study.
Kumada T; Toyoda H; Yasuda S; Tada T; Ogawa S; Takeshima K; Tanaka J; Chayama K; Johnson PJ
Aliment Pharmacol Ther; 2020 Jul; 52(2):359-370. PubMed ID: 32519782
[TBL] [Abstract][Full Text] [Related]
16. Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H
Liver Cancer; 2015 Sep; 4(3):154-62. PubMed ID: 26674263
[TBL] [Abstract][Full Text] [Related]
17. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
[TBL] [Abstract][Full Text] [Related]
18. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.
Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S
Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693
[TBL] [Abstract][Full Text] [Related]
19. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
20. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
